All CYPRESS Articles
-
4.0KIn The PipelineCooperVision and EssilorLuxottica Partner to Commercialize SightGlass Myopia Management Lens
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...
-
2.8KIn The PipelineSightglass Vision Reports 12-month Results for its CYPRESS Study
October 9, 2020 An ongoing CYPRESS study of Sightglass Vision’s novel eyeglasses designed to slow progression of myopia in children “demonstrated the...
-
3.1KIn The PipelineSightGlass Presents CYPRESS Study Baseline Data at International Myopia Conference
CYPRESS is a multi-center, double-masked, randomized controlled pivotal clinical study.